BMO Capital analyst Mark Wilde upgraded Domtar to Market Perform from Underperform with a price target of $36, up from $33, following the company's Q4 results. Wilde said that while he is still conscious of structural declines in paper and risks to a nascent recovery in the pulp market, further downside in the stock appears limited. The analyst added that he applauds recent progress in improving the Personal Care segment and timeliness of Domtar's share repurchase activity. Wilde added that Domtar has well-capitalized white paper assets with re-purposing potential and could also move to sell its Personal Care segment.